Hypertension seems to inevitably cause cardiac remodeling, increasing the mortality of patients. This study aimed to explore the molecular mechanism of CCAAT enhancer binding protein delta (CEBPD)-mediated oxidative stress and inflammation in hypertensive cardiac remodeling. The hypertensive murine model was established through angiotensin-II (Ang II) injection and hypertensive mice underwent overexpressed CEBPD vector injection, cardiac function evaluation and observation of histological changes. The cell model was established by Ang II treatment and transfected with overexpressed CEBPD vector. Cell viability and surface area, oxidative stress [reactive oxygen species (ROS)/superoxide dismutase (SOD)/ superoxide dismutase (LDH)/MDA) were assessed and inflammatory factors (TNF-α/IL-1β/IL-6/IL-10) were determined both in vivo and in vitro. The levels of CEBPD, miR-96-5p, inositol 1,4,5-trisphosphate receptor 1 (IP3R), natriuretic peptide B, and natriuretic peptide A, collagen I, and collagen III in tissues and cells were determined. The binding relationships of CEBPD/miR-96-5p/IP3R 3’UTR were validated. CEBPD was reduced in cardiac tissue of hypertensive mice and CEBPD upregulation improved cardiac function and attenuated fibrosis and hypertrophy, along with reductions of ROS/LDH/MDA/TNF-α/IL-1β/IL-6 and increases in SOD/IL-10. CEBPD enriched on the miR-96-5p promoter to promote miR-96-5p expression, while CEBPD and miR-96-5p negatively regulated IP3R. miR-96-5p silencing/IP3R overexpression reversed the alleviative role of CEBPD overexpression in hypertensive mice. In summary, CEBPD promoted miR-96-5p to negatively regulate IP3R expression to inhibit oxidative stress and inflammation, thereby alleviating hypertensive cardiac remodeling.